Evaluation of a novel Clostridioides difficile-selective growth broth under aerobic conditions.


Journal

Diagnostic microbiology and infectious disease
ISSN: 1879-0070
Titre abrégé: Diagn Microbiol Infect Dis
Pays: United States
ID NLM: 8305899

Informations de publication

Date de publication:
Oct 2023
Historique:
received: 25 03 2023
revised: 22 06 2023
accepted: 08 07 2023
medline: 28 8 2023
pubmed: 4 8 2023
entrez: 3 8 2023
Statut: ppublish

Résumé

A newly developed Clostridioides difficile-selective growth broth, which can be cultured under aerobic conditions, was found to have a sensitivity/specificity (98%/89%) comparable to conventional anaerobic culture methods. This might be a powerful tool for diagnosing Clostridioides difficile infection in resource-limited regions and health care settings in the future.

Identifiants

pubmed: 37536259
pii: S0732-8893(23)00130-X
doi: 10.1016/j.diagmicrobio.2023.116020
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

116020

Informations de copyright

Copyright © 2023 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest This study was conducted with commercial of financial relationships that could be construed as potential conflict of interest. Clostridioides difficile-selective growth broth used in this study was provided free of charge by Kanto Chemical Co (Tokyo, Japan).

Auteurs

Yukitaka Ito (Y)

Division of Clinical Microbiology Laboratory, Toho University Ohashi Medical Center, Meguro, Tokyo, Japan; Department of Infection and prevention, Toho University Ohashi Medical Center, Meguro, Tokyo, Japan. Electronic address: ito-yuki4121@med.toho-u.ac.jp.

Naomi Kaneko (N)

Division of Clinical Microbiology Laboratory, Toho University Ohashi Medical Center, Meguro, Tokyo, Japan.

Mieko Yoshida (M)

Division of Clinical Microbiology Laboratory, Toho University Ohashi Medical Center, Meguro, Tokyo, Japan.

Haruo Nakayama (H)

Division of Clinical Microbiology Laboratory, Toho University Ohashi Medical Center, Meguro, Tokyo, Japan; Department of Infection and prevention, Toho University Ohashi Medical Center, Meguro, Tokyo, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH